Using a wearable device to track daily symptoms of postpartum depression was viewed as acceptable and clinically useful by participants and clinicians.
This initiative will gauge mental health clinicians’ experience with and attitudes around treating pregnant women with mental and substance use disorders in order to identify training gaps.
Interested in telling your story or know of others who wish to share their PPD journey? We seek those who may be interested in participating in the documentary in some capacity.
In this phase II study, sepranolone 10 mg administered subcutaneously during the late luteal phase reduced PMDD symptoms more than placebo.
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Many women experience depression during pregnancy. What is the best way to identify these women?
This review suggests that CBT can be used to target depression during pregnancy and can be delivered using a digital platform.
Prenatal exposure to valproic acid was associated with an increased risk of autism spectrum disorder in exposed children.
Few resources are available to support fathers after pregnancy loss.
This article reviews the research on the effects of antenatal maternal psychological states on offspring.
